Genomic analysis of paired primary and metastatic pancreatic ductal adenocarcinoma tumors

被引:0
|
作者
McIntyre, Caitlin A.
Rudneva, Vasilisa
Richards, Allison L.
Park, Wungki
Jarnagin, William R.
Donoghue, Mark
O'Reilly, Eileen M.
机构
[1] UT Hlth San Antonio, San Antonio, TX USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
10.1200/JCO.2025.43.4_suppl.758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:758 / 758
页数:1
相关论文
共 50 条
  • [41] ALK Rearrangements in Pancreatic Ductal Adenocarcinoma and Neuroendocrine Tumors
    Graham, R. P.
    Oliveira, A. M.
    Zhang, L.
    MODERN PATHOLOGY, 2012, 25 : 443A - 444A
  • [42] Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations
    Xu, Midie
    Yan, Jiuliang
    Hu, Beiyuan
    Wu, Chuntao
    Gu, Haitao
    Qi, Zihao
    Chen, Tao
    Yang, Wenting
    Zheng, Yan
    Dong, Hanguang
    Sheng, Weiqi
    Long, Jiang
    GENES, 2022, 13 (09)
  • [43] Selective Re-operation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma following Primary Pancreatic Resection
    Thomas, R. M.
    Truty, M. J.
    Fleming, J. B.
    Pisters, P. W.
    Lee, J. E.
    Rice, D. C.
    Hofstetter, W. L.
    Wolff, R. A.
    Varadhachary, G. R.
    Wang, H.
    Katz, M. H.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S160 - S160
  • [44] Proteomic analysis of pancreatic ductal adenocarcinoma
    Meleady, Paula
    Rahman, Rozana Abdul
    Henry, Michael
    Moriarty, Michael
    Clynes, Martin
    EXPERT REVIEW OF PROTEOMICS, 2020, 17 (06) : 453 - 467
  • [45] Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma
    Ferga C. Gleeson
    Michael J. Levy
    Current Treatment Options in Gastroenterology, 2018, 16 (4) : 441 - 448
  • [46] Genomic Profiling of Pancreatic Ductal Adenocarcinoma, Intrahepatic and Extrahepatic Cholangiocarcinoma
    Gosse, Matthew
    Sompallae, Ramakrishna
    Guseva, Natalya
    Snow, Anthony
    Bossler, Aaron
    Ma, Deqin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1219 - 1221
  • [47] Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
    Gutierrez, Maria Laura
    Munoz-Bellvis, Luis
    Orfao, Alberto
    CANCERS, 2021, 13 (17)
  • [48] Genomic Profiling of Pancreatic Ductal Adenocarcinoma, Intrahepatic and Extrahepatic Cholangiocarcinoma
    Gosse, Matthew
    Sompallae, Ramakrishna
    Guseva, Natalya
    Snow, Anthony
    Bossler, Aaron
    Ma, Deqin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1219 - 1221
  • [49] Genomic insights and prognostic significance of novel biomarkers in pancreatic ductal adenocarcinoma: A comprehensive analysis
    Chen, Yuling
    Huang, Anle
    Bi, Yuanjie
    Wei, Wei
    Huang, Yongsheng
    Ye, Yuanchun
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 37
  • [50] Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Wong, Hui-li
    Karasinska, Joanna M.
    Jones, Martin
    Eirew, Peter
    Schrader, Kasmintan
    Lim, Howard
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel J.
    CANCER RESEARCH, 2016, 76